Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 20/03/2012
PIL Lustral

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 01/03/2012 and displayed until 20/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 03/10/2011 and displayed until 01/03/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to drug interactions
  • Introduction of new pack/pack size
Updated on 02/08/2010 and displayed until 03/10/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 03/11/2009 and displayed until 02/08/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 23/04/2008 and displayed until 03/11/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 05/03/2008 and displayed until 23/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 30/10/2007 and displayed until 05/03/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 15/03/2006 and displayed until 30/10/2007
Reasons for adding or updating:
  • Change of manufacturer
  • Change of licence holder
  • Change to date of revision
Updated on 10/02/2004 and displayed until 15/03/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 24/06/2003 and displayed until 10/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 17/05/2002 and displayed until 24/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 20/02/2001 and displayed until 17/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 26/01/2000 and displayed until 20/02/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  sertraline hydrochloride